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Adams et al. was the first to demonstrate an association between improved 
outcomes and provider experience in a 1973 study examining complication rates from 
coronary arteriograms.[1]  In this study, a questionnaire was mailed to the directors of 
coronary arteriography laboratories throughout the US.  They found that mortality was 
eight times higher in institutions performing fewer than 200 examinations per two-year 
period compared to institutions performing more than 800 examinations per two-year 
period.  It was not until 1979, however, that efforts to systematically study outcomes in 
surgery were made by Luft and colleagues.[2]  They demonstrated lower mortality rates 
at high-volume centers compared with low-volume centers for several high risk 
procedures, such as coronary artery bypass graft surgery (CABG) and vascular surgery.  
This landmark study set the stage for outcomes research in surgery.  Over the past 
decade, additional studies have continued to show higher surgeon or hospital volumes to 
be associated with improved patient outcomes. [3-13]  To what degree surgeon versus 
hospital volume each contribute to outcomes is controversial and depends on the 
procedure examined.  Nevertheless, formal recommendations encouraging certain high-
risk procedures be performed at high-volume hospitals began as early as 2000 by the 
Leapfrog group and other policy initiatives.[14, 15]  Formal recommendations for 
surgeon volume, on the other hand, have been lacking.  There has been mounting 
evidence, particularly in the last decade, that surgeon volume is associated with improved 
patient outcomes, independent of hospital volume.  To what measure these data have 
influenced referral patterns from low- to high-volume surgeons is unknown.   
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Hospital Volume 
Health services research in surgery has led payers to practice so-called “evidence-
based hospital referral” (EHR).  The most visible of such efforts was initiated by the 
Leapfrog group in 2000.  This organization, which was initiated as a result of a coalition 
of more than 150 public and private healthcare purchasers representing 40 million people, 
sought to improve patient outcomes by encouraging referrals to hospitals for certain 
procedures which met minimal-volume standards.  Leapfrog establishes minimum 
caseloads for certain procedures if it deems there are sufficient data to support an 
association between higher hospital volume and improved outcomes (e.g. mortality).  The 
original Leapfrog procedures were CABG, coronary angioplasty, elective repair of 
abdominal aortic aneurysm, and esophagectomy for cancer.[14]  Leapfrog’s EHR 
strategy established rigid thresholds defining high- and low-volume hospitals.  These 
thresholds were established based on data from clinical research showing outcome 
differences as a function of hospital volume.  According to Birkmeyer, a proponent of 
EHR, this initiative has the potential to save 7,602 lives year in the U.S. if implemented 
nationally.[14] 
Surgeon Volume 
The Leapfrog group has focused on hospital volume as a proxy for quality of care 
in surgical procedures.  There is mounting evidence that individual surgeon experience 
also is associated with outcomes from several surgical procedures, independent of 
hospital volume.  Chowdhury et al. systematically reviewed the literature examining the 
impact of surgeon volume on patient outcomes.[16]  In this review, 58 studies focusing 
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on surgeon-volume outcome relationships were analyzed.  Outcomes varied by study 
design; each examined either mortality, hospital length of stay (LOS), and/or 
complications.  Procedures included: colectomy, esophagectomy, pancreatic resection, 
gastrectomy, and lung lobectomy for cancer; two vascular procedures, CABG and carotid 
endarterectomy (CEA); and thyroidectomy for both benign and malignant disease.  Forty 
three studies (74%) concluded that high surgeon volume was associated with 
significantly better overall outcomes.     
For thyroidectomy, Chowdhury examined a population based study by Sosa et al. 
examining clinical and economic outcomes following thyroidectomy in relation to 
surgeon experience.[17]  While several small institutional studies had shown that high-
volume surgeons had low complication rates, they provided no benchmark for 
comparison to ordinary community surgeons and did not examine outcomes on a 
population scale. [17]  This is important because the majority of thyroid surgeries are 
performed by general surgeons.[18]  In this study, Sosa et al. used a cross-sectional 
analysis of hospital discharge data from the Maryland Health Services Cost Review 
Commission to identify patients who underwent a primary procedure of thyroidectomy 
for any reason between 1991 and 1996.  Independent variables included thyroid 
diagnosis, age, gender, race, payer status, and the Dartmouth-Manitoba adaptation of the 
Charlson comorbidity score.  Surgeon experience was modeled as a four way categorical 
variable (1-9, 10-29, 30-100, and >100 thyroid procedures per year). According to this 
study, there was a significant association between increased surgeon volume and 
improved outcomes.  The highest volume surgeons in this study had the shortest LOS 
both before and after adjustment for differences in patient case-mix.  Importantly, in a 
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stratified multivariate analysis, they found that surgeon experience was a particularly 
important predictor of outcomes in patients with complex or severe disease (e.g. thyroid 
cancer patients who required a total thyroidectomy versus a partial thyroidectomy for a 
benign adenoma).  The highest volume surgeon group had 75% fewer postsurgical 
complications (p<0.001) and the lowest charges (p<0.001) compared to low-volume 
surgeons.  Sosa et al. estimated that more than 20% of complications and 1700 hospital 
days could have been saved in Maryland if all thyroidectomies were performed by high-
volume surgeons.  As a result, they concluded that patients undergoing thyroidectomy, 
and especially those with complex or severe thyroid disease, should be directed to a high-
volume surgeon.   
Other studies have examined the importance of surgeon experience as a predictor 
of outcomes for oncologic procedures.  For example, Hannan et al. examined the 
influence of surgeon volume and post-operative mortality for colectomy, gastrectomy, 
and lung lobectomy in patients with cancer.[10]  This study used the New York 
Statewide Planning and Research Cooperative System to identify more than 32,000 
hospital inpatients with a cancer diagnosis that underwent one of the aforementioned 
procedures.  This study simultaneously examined the impact of both surgeon and hospital 
volume.  For colectomy, patients were identified using a principal procedure code for 
colectomy (e.g. right hemicolectomy, resection of the transerve colon, left 
hemicolectomy, or sigmoidectomy) and a related cancer diagnosis code (e.g. colon 
cancer).  Similar strategies were used to identify patients undergoing lung lobectomy and 
gastrectomy.  Comorbidities were identified using secondary diagnosis data.  Adjustment 
was made using patient age, gender, race, and insurance status variables in their 
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multivariate models.  Overall, the authors found that high surgeon volume was 
independently associated with inpatient mortality for all three procedures in a step-wise, 
dose-dependent fashion as defined by surgeon-volume quartile.  Surgeons in the 75th 
percentile or above, for example, had an adjusted mortality rate that was 5.74 (p<.0001) 
times lower than surgeons in the 25th percentile for gastrectomy, 1.86 (p<.0001) times 
lower for colectomy, and 1.12 (p<.08) times lower lung lobectomy. 
Porter and colleagues examined the prognostic importance of surgeon experience 
for rectal cancer using a prospective study design with historic controls.  They reviewed 
the records of patients with >5 year follow up from 52 surgeons at five hospitals over an 
eight year period in order to assess whether surgeon volume is associated with cancer 
patients’ risk for local recurrence and survival.  Six hundred eighty three patients were 
identified.  All patients undergoing potentially curative low anterior resection (LAR) or 
abdominoperineal resection for adenocarcinoma of the rectum were included in the study.  
Demographic, preoperative, intraoperative, pathologic, adjuvant therapy, and outcome 
variables were obtained through a standardized review of hospital and physician charts.  
They found that disease specific survival rates were significantly lower for high-volume 
colorectal surgeons compared with low-volume surgeons.  For example, patients who 
underwent surgery by a low-volume surgeon were 1.52 times (95% confidence interval 
1.05-2.20) more likely to die of rectal cancer than patients treated by a high-volume 
colorectal specialist.  The operative approach to these patients differed between surgeon 
groups.  Surgeons performing <21 resections over the study period were significantly less 
likely to perform an LAR and preserve the anal sphincter.   
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Statement of Purpose 
Evidence that improved outcomes are associated with high surgeon-volume 
independent of hospital volume for several specialized surgical procedures has mounted 
in the last decade.[16]  The degree to which this evidence has influenced the number of 
patients who see a high- compared to low-volume surgeon is unknown.  Further, it is 
unknown on a population level how such referral pattern shifts over time are associated 
with patient outcomes (e.g. mortality or LOS).  Thus, we sought to answer the following 
two questions: 1) Are more patients being referred to high-volume surgeons and away 
from low-volume surgeons over time?  2) Are patient outcomes still better now when 
high-volume surgeons perform the procedure compared to low-volume surgeons? 
Aims of Study 
1) To determine if high-volume surgeon share has increased between 1999 and 2005 for 
surgical procedures for which abundant data exist supporting a positive surgeon-
volume / patient-outcome relationship. 
2) To measure whether patient outcomes (e.g. LOS and mortality1) are still different in 
2005 compared to 1999 when high-volume surgeons perform a procedure compared 
to low-volume surgeons. 
 
 
                                                 
1 For thyroidectomy, outcomes of interest are LOS and endocrine-specific complications, since post-
operative mortality is extremely rare. 
 10
Hypothesis 
The hypothesis in this study was that there will be an increase in the proportion of 
patients who sought care from a high-volume surgeon in 2005 compared to 1999.  This is 
likely associated with improved patient outcomes, and high-volume surgeons will 
continue to have superior outcomes compared to low-volume surgeons over time. 
Methods 
Data Source 
This study is a cross-sectional analysis comparing 1999 and 2005 patient 
discharge information obtained from the Health Care Utilization Project National 
Inpatient Sample (HCUP-NIS) administrative database.  The Agency for Healthcare 
Research and Quality (AHRQ), one of 12 agencies within the Department of Health and 
Human Services, maintains HCUP-NIS.[19]  HCUP-NIS is the largest all-payer inpatient 
database in the U.S., with data from approximately 8 million hospital stays each year.  
There are more than 900 hospitals in this dataset, randomly selected within strata for 
region, number of hospital beds, teaching status, urban vs. rural location, and hospital 
ownership.  HCUP-NIS contains data from 24 states in 1999, and 37 states in 2005 












discharges in the 
NIS unweighted 
Number of 
discharges in the 
NIS weighted for 
national 
estimates 
States in sample 
1999 984 7198929 35467673 
AZ CA CO CT FL GA HI IL IA KS MD 
MA ME MO NJ NY OR PA SC TN UT 
VA WA WI
2005 1054 7995048 39163834 
(Added states) KY NC TX WV MI MN 
NE NH RI VT NV OH SD IN (VA 
removed)
 
These datasets represent a 20% sample of all inpatient admissions to acute care 
hospitals nationwide.[19]  The NIS is a publicly available dataset and contains no 
personal identifying information.  This study was therefore deemed exempt from Human 
Investigation Committee approval at our institution (HIC # 0801003415).   
We obtained data from 1999 and 2005 in order to assess whether high-volume 
surgeon share increased over time for procedures shown in the literature to have strong 
surgeon-volume associations.  In order to do this, we relied upon a recently published 
systematic review by Chowdhury from the British Journal of Surgery, which examined 
evidence regarding the impact of surgeon volume on patient outcomes.[16]  In this 
review, a standardized methodology was used to assess study quality.  We abstracted 
procedures which had particularly strong evidence for a surgeon volume outcome 
relationship.  These studies were closely examined to assure that the outcome of interest 
was a primary endpoint used in our study (e.g. inpatient mortality as opposed to 5-year 
survival).   
Procedures deemed appropriate for inclusion in this study are: colectomy, 
esophagectomy, pancreatic resection, gastrectomy, and lung lobectomy for cancer; two 
vascular procedures, CABG and CEA; and thyroidectomy for both benign and malignant 
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disease.  Primary outcomes of interest were LOS or mortality (or endocrine 
complications for thyroidectomy). 
We used primary procedure and diagnosis codes from the International 
Classification of Diseases, Ninth Revision (ICD-9) or clinical classification system 
(CCS) to identify adult patients (≥18 years) who underwent one of these procedures 
(Appendix 1).  For the oncologic procedures, patients were included if they had an 
associated primary diagnosis of cancer.  For colectomy, four patients were excluded who 
had a primary procedure code for Soave or Duhamel rectal resection (which are pediatric 
procedures) as they likely represent a coding error. For CABG and CEA, we excluded 
patients who had a secondary procedure indicating other cardiac and peripheral vascular 
procedures that might have increased the likelihood of a negative outcome not due to 
CABG or CEA.  For CABG, this included secondary procedures such as cardiac valve 
repair or CEA; for CEA, this included secondary procedures on valves or vessels of the 
heart.   
Patients were also excluded if they did not have an associated surgeon identifier.  
Excluded patients represented between 40-55% of our sample, depending on the 
procedure.  We therefore compared hospital and patient characteristics between patients 
who had a surgeon identifier and those who did not in order to make sure that our cohort 
was an appropriate representative sample. 
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Provider & Patient Characteristics 
Surgeon Characteristics 
In order to assess how high-volume surgeon share changed between 1999 and 
2005, we had to establish annual volume threshold definitions of a high- versus low 
volume-surgeon.  The definitions of high- and low-volume surgeon varies between 
different operations, and in some instances even between studies examining the same 
operation.[16]  We relied upon Chowdhury’s systematic review which defined surgeon 
volume thresholds according to the most rigorously performed studies for each 
procedure.  Surgeon volume was modeled as a three-way categorical variable for high-
volume, medium volume, and low-volume surgeons. (Table 2) 









Colectomy 11 12-20 21
Esophagectomy 4 5-11 12
Pancreas Resection 1 2-4 5
Gastrectomy 2 2-4 5
Lung Lobectomy 22 23-49 50
 
Other
Thyroidectomy 9 10-29 30
CEA 5 6-49 50
CABG 50 51-149 150
 
Surgeons were identified in HCUP-NIS as the admitting physicians for patients 
undergoing a procedure of interest.  Previous studies using administrative databases have 
shown this method to be reliable.[20] 
 14
Hospital Characteristics 
Independent hospital variables used in this study included hospital location (urban 
vs. rural); geographic region (northeast, midwest, south, west); and teaching status 
(teaching hospital vs. non-teaching).  Since hospital volume is related to improved 
outcomes for many procedures, we created a dichotomous variable (low-volume or high-
volume hospital) at the 75%th percentile in order to control for hospital volume 
phenemena.  This value is comparable to Leapfrog Group hospital volume 
thresholds.[14] 
Patient Characteristics 
Independent patient demographic variables included gender, median household 
income ($1-35,999, $36,000-44,999, $45,000-58999, and ≥$59,000), race (white, black, 
Hispanic, other) and payer type (Medicare, Medicaid, private HMO, self-pay).  Since 
HCUP-NIS does not provide data regarding elective versus emergent surgery in 1999, 
hospital admission type was used as a proxy.  Non-routine hospital admission was 
defined as admission from the emergency room, another hospital or facility, or jail.  
Patient age was modeled as a three-way categorical variable (18-44, 45-64, ≥65 years) as 
has been done in similar studies examining discharge information for surgical 
procedures.[17, 21]  
A modified comorbidity score was created for each procedure of interest using 
Deyo’s method of adapting a Charlson comorbidity score from an administrative 
database.[22, 23]  We modified the comorbidity definition for each procedure group to 
exclude conditions likely to reflect a patient’s primary reason for admission or a 
complication of their procedure.[24, 25]  Since this modified comorbidity score has not 
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been validated for the procedures in our study, we benchmarked our scores with those 
published in previous studies.  We found our scores comparable.[24, 25]  This score was 
treated in all calculations as an ordinal variable; for clarity of presentation, we present it 
as a dichotomous variable (<3 not sick, ≥3 sick). 
Patient Outcomes 
Primary outcomes of interest were: inpatient mortality (for all procedures except 
thyroidectomy); endocrine-specific complications for thyroidectomy; and mean LOS. 
We identified endocrine-specific complications for thyroidectomy using ICD-9 
diagnostic codes in order to identify complications unique to thyroidectomy (Table 3).  
Since it is not possible to rate complication severity, this outcome was treated as a 
binomial variable (no complication vs. one or more).  This method of analyzing 
complications in an administrative database has been used by Sosa and others.[17] 
 
Table 3: Thyroidectomy Complications  
               (ICD-9 Codes & Diagnosis) 
Paralysis of vocal cords or larynx  
 478.30 laryngoplegia  
 478.31 unilateral partial  
 478.32 unilateral complete  
 478.33 bilateral partial  
 478.34 bilateral complete  
Other   
 252.1 hypoparathyroidism  
 275.41 hypocalcemia  




In order to determine how high-volume surgeon share has changed between 1999 
and 2005, surgeon volume groups were compared by year using the chi square statistic 
for each procedure.   
The distribution of patient characteristics among surgeon volume groups were 
compared using analysis of variance (ANOVA) for continuous variables (e.g. LOS) and 
the chi square statistic for categorical variables (e.g. race, hospital region, etc).  Bivariate 
analyses were used to determine which variables were associated with our outcomes of 
interest (i.e. mortality or LOS).  These analyses subsequently guided the selection of 
variables for adjustment in the multivariate regression models.   
Multivariate logistic regression models were used to determine if mortality (or 
endocrine complications for thyroidectomy) was related to surgeon volume in 1999 and 
2005.  Adjustments were made for patient and provider characteristics including patient 
age, race, gender, income, admission type, comorbidity score, and insurance type; and 
hospital volume, region, teaching status, and location.  In addition, adjustments were 
made for the use of laparoscopy for colectomy and thoracoscopy for lung lobectomy, 
since these technologic advances conceivably influenced outcomes.  Multivariate linear 
regression models were used to determine if LOS was related to surgeon volume between 
years adjusting for the same patient and provider variables indicated above.   
Data analysis and management were performed using SPSS Version 14.0 
(Chicago, IL).  All probability values are the results of two-sided tests, and values less 
than or equal to 0.05 are reported as significant.   
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Miscellaneous 
Drs. Julie Ann Sosa and Sanziana Roman guided me through all steps of this 
project.  The design idea for this study is credited to Dr. Sosa.  All database work was 
performed by me, with occasional assistance from two fellow medical students, Kevin 
Cheung and Charles Tuggle.  All statistical analyses were performed by me, with 
oversight from Dr. Sosa.  In addition, I met with statistician Dr. James Dziura and Robert 
Wood Johnson Scholar Dr. Nancy Kim on one occasion for assurances and ideas 
regarding my methodology.  The writing of this manuscript was accomplished entirely by 
me, with editing from Drs. Sosa and Roman.  I also received minor editing suggestions 
from fellow medical student Sophia Liu.  
Results 
Provider Characteristics 
There were a total of 16,230 unique surgeons identified in the 1999 and 2005 
HCUP-NIS database who performed a procedure of interest.  High-volume surgeons 
made up a minority of providers for all procedure groups in both years (Table 8).   
Overall, there were significant differences in hospital characteristics between 
surgeon-volume groups for all procedures (Table 4).  In 1999, high-volume surgeons 
operated more often than low-volume surgeons in the south for all procedures except 
esophagectomy and thyroidectomy.  For these procedures, the high-volume surgeons 
operated most often in the northeast.  This trend among high-volume surgeons operating 
most often in the south was maintained in 2005 for colectomy and lung lobectomy.  Thus, 
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relative to low-volume surgeons, high-volume surgeons shifted away from operating in 
the south for most procedures.   
High-volume surgeons operated in urban hospitals (as opposed to rural) more 
often than low-volume surgeons for all procedures except CABG in 1999, and all 
procedures except lung lobectomy in 2005.  Likewise, high-volume surgeons practiced 
more often at a teaching hospital for all procedures except CABG; however, for most 
procedures this proportion decreased over time.  CABG was the exception; in 1999 more 
low-volume surgeons (75% compared to 55% for high-volume surgeons p<0.001) were at 
a teaching hospital, whereas in 2005 only 43% of low-volume surgeons were at a 
teaching hospital (compared with 86% for high-volume surgeons p<0.001). 
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Table 4: Hospital Characteristics According to Surgeon Volume by Year ±
Calander Year 1999 2005
Surgeon Volume Cohorts High Med Low p value* High Med Low p value*
Oncologic Procedures
Colectomy
Geographic Region 0.001 0.001
Northeast 18.9 31.2 27.6 24.7 33.8 26.4
South 63.1 57.2 54.1 47.8 41.8 44.3
West 2.1 5.1 9.7 7.1 11.1 13.6
Midwest 15.9 6.6 8.6 20.4 13.3 15.7
Urban Hospital 98.6 83.5 82.9 0.001 93.6 90.1 82.8 0.001
Teaching Hospital 62.0 43.0 37.0 0.001 48.5 42.7 32.2 0.001
High Volume Hospital 58.6 27.9 21.2 0.001 46.2 31.3 19.9 0.001
Esophagectomy
Geographic Region 0.001 0.001
Northeast 33.8 22.0 24.5 8.8 16.1 13.8
South 29.7 14.6 57.8 28.8 16.1 40.9
West 17.6 17.1 13.6 14.4 27.4 20.1
Midwest 18.9 46.3 4.1 48.1 40.3 25.2
Urban Hospital 100.0 100.0 94.6 0.040 100.0 83.9 95.6 0.001
Teaching Hospital 100.0 100.0 63.3 0.001 100.0 75.8 53.5 0.001
High Volume Hospital 52.7 46.3 3.4 0.001 82.5 33.9 4.4 0.001
Pancreas Resection
Geographic Region 0.001 0.008
Northeast 8.7 27.3 20.0 27.9 20.4 34.2
South 65.8 60.0 57.9 28.9 37.9 39.2
West 6.8 12.7 12.4 29.9 20.4 11.4
Midwest 18.6 0.0 9.7 13.2 21.4 15.2
Urban Hospital 100.0 100.0 97.2 0.049 94.9 96.1 100.0 NS
Teaching Hospital 95.7 70.9 55.9 0.001 82.2 80.6 63.3 0.002
High Volume Hospital 75.8 3.6 4.1 0.001 46.2 20.4 2.5 0.001
Gastrectomy
Geographic Region 0.002 0.041
Northeast 33.0 31.0 29.7 36.6 37.6 29.8
South 62.0 47.7 57.0 46.2 38.2 46.6
West 0.0 8.4 7.4 9.7 8.1 11.6
Midwest 5.0 12.9 5.9 7.5 16.2 12.0
Urban Hospital 100.0 94.2 89.8 0.001 100.0 96.0 90.5 0.001
Teaching Hospital 92.0 70.3 46.0 0.001 88.7 56.6 45.7 0.001
High Volume Hospital 87.0 27.1 15.6 0.001 73.7 26.6 18.8 0.001
Lung Lobectomy
Geographic Region 0.001 0.001
Northeast 0.0 32.9 24.6 30.9 30.5 20.5
South 76.8 43.3 60.6 68.9 43.4 46.7
West 0.0 0.0 9.7 0.0 12.7 14.9
Midwest 23.2 23.8 5.1 0.1 13.3 17.8
Urban Hospital 100.0 100.0 94.5 0.001 89.8 97.0 93.9 0.001
Teaching Hospital 92.0 78.8 47.0 0.001 85.4 66.2 38.4 0.001
High Volume Hospital 78.3 43.6 11.7 0.001 93.1 43.7 13.2 0.001
Other Procedures
CABG
Geographic Region 0.001 0.001
Northeast 30.3 24.1 15.0 11.0 28.8 12.0
South 58.4 57.6 56.6 70.7 46.1 59.5
West 3.4 6.6 15.9 9.8 9.5 14.2
Midwest 7.9 11.7 12.5 8.5 15.6 14.2
Urban Hospital 99.0 96.4 99.8 0.001 100.0 97.4 95.7 0.001
Teaching Hospital 54.9 63.6 75.0 0.001 86.3 47.8 43.1 0.001
High Volume Hospital 50.1 26.9 27.7 0.001 49.5 9.9 18.1 0.001
CEA
Geographic Region 0.001 0.001
Northeast 19.9 24.2 23.9 20.1 22.2 24.2
South 72.4 58.3 54.1 48.0 50.8 51.0
West 3.8 7.5 10.7 6.5 12.8 10.9
Midwest 3.9 10.1 11.3 25.4 14.2 13.9
Hospital Location 94.3 90.2 90.4 0.001 97.4 87.5 92.6 0.001
Teaching Hospital 45.1 44.0 40.2 0.001 49.3 32.9 38.6 0.001
High Volume Hospital 55.5 26.3 18.0 0.001 34.5 19.1 9.3 0.001
Thyroidectomy
Geographic Region 0.001 0.001
Northeast 63.4 37.0 25.6 41.4 34.8 22.4
South 33.0 51.4 57.3 19.5 37.9 47.0
West 0.0 9.0 10.9 17.2 13.0 14.4
Midwest 3.6 2.7 6.2 22.0 14.4 16.2
Urban Hospital 99.8 97.6 85.9 99.9 97.5 87.9 0.001
Teaching Hospital 93.7 63.5 45.6 0.001 62.8 49.7 38.6 0.001
High Volume Hospital 75.0 23.1 8.1 0.001 74.3 23.0 17.8 0.001
± values given as percentage
NS = not significant
* Based on Chi squared analyses; signifiance set at α=0.05   
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Patient Characteristics 
A total of 250,949 patients were identified in the HCUP-NIS 1999 or 2005 
database who underwent a procedure in this study (Table 6).  Forty two percent 
(n=105,868) of patients were not included in further analyses because they did not have 
an associated surgeon identifier (Table 5).  These patients were found not to have 
significant demographic or clinical differences compared to patients who had a surgeon 
identifier.   
 




































Patients With Surgeon ID 14152 262 361 1016 4411 35887 16741 5427
Patients Missing Surgeon ID 10174 314 264 852 3150 28006 10627 4167
% Missing Surgeon ID 41.8 54.5 42.2 45.6 41.7 43.8 38.8 43.4
Unique Surgeon Identifiers 2851 128 179 704 766 970 1572 1600
Patients With Surgeon ID 12611 381 379 919 5168 26167 14105 7094
Patients Missing Surgeon ID 9851 253 333 723 3573 19222 9554 4805
% Missing Surgeon ID 43.9 39.9 46.8 44.0 40.9 42.3 40.4 40.4
Unique Surgeon Identifiers 2329 116 142 541 674 959 1232 1467
Year 2005
 
For the oncologic procedures, high- and low-volume surgeons operated on an 
equal proportion of elderly patients (those aged >65 years) in both years for colectomy, 
esophagectomy, pancreas resection, and lung lobectomy; for gastrectomy, high-volume 
surgeons operated less frequently on the elderly than low-volume surgeons in 1999 (52% 
vs. 67% p<0.002 for gastrectomy), but this difference narrowed by 2005 (56.5% vs. 
63.6% p=NS for gastrectomy).  For vascular procedures CABG and CEA, high- and low-
volume surgeons operated on an equal proportion of elderly patients.  
For all procedures except gastrectomy and CABG, high- and low-volume 
surgeons operated on an equal share of female patients in both time periods.  For 
 21
gastrectomy in 1999, only 27% of patients seen by high-volume surgeons were female 
compared to 41% by low-volume surgeons (p<0.005), but this difference narrowed to 
similar values by 2005.  For CABG, female patients made up the minority of surgeons’ 
practices in both years.  Low-volume surgeon practices made up the greatest proportion 
of females in 1999; this switched to high-volume surgeons by 2005.   
In 1999, high-volume surgeons more often cared for patients in the highest annual 
income group (≥$59,000) for all procedures except CEA; this pattern dissipated between 
surgeon-volume groups by 2005 for gastrectomy, lung lobectomy, CABG, and 
thyroidectomy.   
In both years, high-volume surgeons saw a higher proportion of patients with 
private HMO insurance compared to low-volume surgeons for colectomy (34% vs. 30% 
p<0.001 in 1999; 35% vs. 30% in 2005), gastrectomy (51% vs. 31% p<0.004 in 1999; 
40% vs. 29% p<0.009 in 2005), lung lobectomy (39% vs. 35% p=NS in 1999; 46% vs. 
34% p<0.001 in 2005), and thyroidectomy (81% vs. 63% p<0.001 in 1999; 73% vs. 60% 
p<0.001 in 2005).  Both high- and low- surgeon volume groups saw equal proportions of 
patients with private HMO insurance in both years for esophagectomy and pancreas 
resection; in CABG or CEA, however, high-volume surgeons saw these patients less 
often compared to medium- or low-volume surgeons. 
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Table 6: Patient Characteristics According to Surgeon Volume by Year ±
Calander Year 1999 2005
Surgeon Volume Cohort High Med Low p value* High Med Low p value*
Oncologic Procedures
Colectomy
Number of Patients 2096 2851 9204 2060 3042 7507
Age ≥65 67.1 73.3 70.0 0.001 64.6 65.9 66.2 NS
Female sex 48.1 50.5 50.3 NS 50.3 50.7 50.5 NS
Household income ≥ $59,000 33.7 24.9 27.6 0.001 30.6 27.0 22.5 0.001
Primary payer private HMO 33.8 29.0 29.6 0.001 34.7 32.9 30.1 0.001
Non-white race 18.5 14.0 15.8 0.001 15.5 15.4 21.1 0.001
Charlson comorbidity ≥3 44.3 46.0 46.0 NS 40.1 43.1 44.5 0.002
Non-routine admission 12.5 15.9 20.9 0.001 11.7 16.9 23.1 0.001
Esophagectomy
Number of Patients 74 41 147 159 62 159
Age ≥65 44.6 48.8 47.6 NS 53.1 54.8 44.7 NS
Female sex 16.2 19.5 19.0 NS 20.0 17.7 14.5 NS
Household income ≥ $59,000 34.7 17.5 30.5 NS 23.6 13.6 16.7 NS
Primary payer private HMO 48.6 43.9 44.2 NS 47.5 40.3 39.6 NS
Non-white race 3.3 20.0 19.3 0.039 2.7 13.3 13.7 0.001
Charlson comorbidity ≥3 35.1 34.1 40.1 NS 33.1 32.3 35.8 NS
Non-routine admission 27.0 0.0 8.5 0.001 1.3 0.0 5.7 0.021
Pancreas Resection
Number of Patients 161 55 145 197 103 78
Age ≥65 60.9 70.9 56.6 NS 61.9 54.4 54.4 NS
Female sex 50.9 52.7 48.3 NS 50.3 48.5 49.4 NS
Household income ≥ $59,000 40.3 27.1 26.2 NS 30.4 21.8 23.0 NS
Primary payer private HMO 41.6 32.7 40.3 NS 30.4 21.8 23.0 NS
Non-white race 8.3 24.4 24 0.001 17.7 20.8 31.9 NS
Charlson comorbidity ≥3 74.5 70.9 60.7 0.031 59.4 57.3 64.6 NS
Non-routine admission 31.9 14.3 24.3 0.039 10 10.8 24.4 0.005
Gastrectomy
Number of Patients 100 155 761 186 173 560
Age ≥65 52.0 61.3 67.4 0.002 56.5 56.6 63.6 NS
Female sex 27.0 31.2 40.7 0.005 39.2 35.3 42.5 NS
Household income ≥ $59,000 51.6 27.7 27.6 0.001 24.2 27.1 21.9 NS
Primary payer private HMO 51.0 28.6 31.0 0.004 39.5 30.6 29.2 0.009
Non-white race 23.3 32.1 31.1 NS 34.2 37.7 36.7 0.001
Charlson comorbidity ≥3 67.0 62.6 58.2 NS 48.9 52.6 60.2 0.014
Non-routine admission 22.0 19.1 21.2 NS 9.7 12.7 21.6 0.001
Lung Lobectomy
Number of Patients 314 690 3407 734 1114 3319
Age ≥65 58.3 63.8 63.4 NS 61.6 63.7 62.0 NS
Female sex 48.4 47.7 45.1 NS 50.3 49.7 50.2 NS
Household income ≥ $59,000 44.4 32.8 28.5 0.001 14.6 33.1 22.8 0.001
Primary payer private HMO 39.0 32.9 35.0 NS 45.6 30.2 33.6 0.001
Non-white race 12.0 9.5 13.6 0.001 3.3 11.1 13.2 0.001
Charlson comorbidity ≥3 70.7 76.7 78.0 0.012 72.2 80.1 79.7 0.001
Non-routine admission 33.4 4.6 6.3 0.001 0.5 2.3 4.0 0.001
Other Procedures
CABG
Number of Patients 14726 15990 5167 5467 13633 6992
Age ≥65 58.9 56.4 54.6 0.001 54.4 56.2 50.7 0.001
Female sex 28.4 28.0 31.2 0.001 28.8 27.3 27.5 0.118
Household income ≥ $59,000 31.7 28.0 24.5 0.001 17.9 20.6 16.7 0.001
Primary payer private HMO 36.6 38.4 36.2 0.001 36.3 34.3 38.6 0.001
Non-white race 11.9 10.5 17.1 0.001 16.4 18.8 23.0 0.001
Charlson comorbidity ≥3 11.4 11.3 10.4 NS 14.6 13.7 14.6 NS
Non-routine admission 41.6 43.8 51.7 0.001 43.4 39.7 43.7 0.001
CEA
Number of Patients 4420 10440 1881 3014 9750 1340
Age ≥65 77.7 77.6 75.2 0.023 75.9 75.7 72.4 0.018
Female sex 43.2 43.0 43.6 NS 42.9 43.1 43.1 NS
Household income ≥ $59,000 21.6 27.9 24.6 0.001 22.0 21.0 20.3 0.007
Primary payer private HMO 21.9 23.9 26.0 0.001 21.5 22.2 26.0 0.001
Non-white race 7.4 6.0 12.2 0.001 6.5 9.6 13.6 0.001
Charlson comorbidity ≥3 13.1 12.9 13.9 NS 15.1 15.2 16.1 NS
Non-routine admission 9.6 11.9 19.8 0.001 7.5 10.0 15.5 0.001
Thyroidectomy
Number of Patients 1218 1012 3197 1789 2100 3204
Age ≥65 14.1 19.4 23.5 0.001 19.8 22.4 24.7 0.001
Female sex 82.4 81.6 82.0 NS 78.8 81.2 79.4 NS
Household income ≥ $59,000 55.7 38.3 29.9 0.001 38.3 27.4 26.4 0.001
Primary payer private HMO 80.9 70.5 63.2 0.001 72.8 62.9 60.0 0.001
Non-white race 24.1 22.7 26.2 0.001 25.2 30.3 28.8 0.001
Charlson comorbidity ≥3 7.1 6.8 8.0 NS 7.9 7.9 8.0 NS
Non-routine admission 14.0 0.7 4.9 0.001 0.5 3.0 3.1 0.001
± except for number of patients, all values given as percentage of patients within volume category
NS = not significant
* Based on Chi squared analyses; signifiance set at α=0.05  
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The ethnic makeup of patients seen by each surgeon volume group varied widely 
between procedure and year.  Differences in the proportion of non-white patients seen by 
low- and high-volume surgeon groups were most pronounced for esophagectomy (19% 
for low-volume vs. 3% for high-volume p<0.039 in 1999; 14% vs. 3% p<0.001 in 2005), 
CABG (17% vs. 12% <0.001 in 1999; 23% vs. 16% p<0.001 in 2005), and CEA (12% 
vs. 7% p<0.001 in 1999; 14% vs. 7% p<0.001 in 2005).  Of note, for esophagectomy and 
CEA, the percentage of non-white patients seen by high-volume surgeons remained 
constant in both time periods.  For lung lobectomy, the proportion of non-white patients 
seen by high-volume surgeons fell dramatically over time; whereas 12% of patients seen 
by high-volume surgeons for this procedure were non-white in 1999, only 3% were in 
2005.  The opposite was true for pancreas resection; in 1999, 8.3% of patients seen by 
high-volume surgeons were non-white compared 18% in 2005.  
Charlson comorbity scores for patients in the high-volume surgeons group were 
not significantly higher than low-volume surgeons for any procedure except pancreas 
resection in 1999.  Differences were statistically non-significant across all surgeon-
volume groups in both years for esophagectomy, CABG, CEA, and thyroidectomy.  For 
colectomy and gastrectomy, there was an increase in the proportion of patients with a 
Charlson comorbidity score ≥3 seen by low-volume surgeons from 1999 to 2005.   
High-volume surgeons more often saw patients who were admitted to the hospital 
in a non-routine fashion in 1999 for pancreas resection, gastrectomy, lung lobectomy, 
esophagectomy, and thyroidectomy.  This changed by 2005, when low-volume surgeons 
were instead the group whose practice made up the greatest portion of patients admitted 
in a non-routine fashion.  For colectomy and CEA, low-volume surgeons had the greatest 
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proportion of non-routinely admitted patients in both years compared to high-volume 
surgeons (for colectomy 21% vs. 13% p<0.001 in 1999 and 23% vs. 12% p<0001 in 
2005; for CEA 20% vs. 10% p<0.001 in 1999 and 15% vs. 8% p<0.001 in 2005).  For 
CABG, the proportion of patients seen in a non-routine fashion shifted away from low- to 
high-volume surgeons between 1999 and 2005 (52% vs. 42% p<0.001 in 1999 and 44% 
vs. 43% p<0.001 in 2005). 
For all procedures in 1999, a majority of high-volume surgeons performed their 
operations at a high-volume hospital (p<0.001).  In 2005, there was a decline for 
colectomy (59% in 1999 to 46% in 2005), pancreatectomy (76% in 1999 to 46% in 
2005), and CEA (56% in 1999 to 35% in 2005).  Of note, both esophagectomy and lung-
lobectomy had a large increase in the proportion of high-volume surgeons operating at a 
high-volume hospital. 
Surgeon Volume Shifts  
Overall, there was a significant increase (p<0.001) in high-volume surgeons share 
between 1999 and 2005 for all procedures except CABG and CEA (Table 7).  The most 
dramatic relative increases were seen for gastrectomy (106%), lung lobectomy(100%), 
and esophagectomy(49%).  The percentage of patients that were operated by each of the 
three surgeon volume groups is represented graphically in appendix 2.  
For all procedures, medium-volume surgeons gained patient shares between 1999 
and 2005; this was most dramatic for pancreatectomy (79%) and thyroidectomy (58%).   
Low-volume surgeon share decreased for all procedures except CABG.  The most 
dramatic relative movements away from the low-volume surgeons were for pancreas 




Table 7: Surgeon Volume Shares by Year
High Volume Surgeon Share (%)
1999 2005 % Change
Oncologic
Colectomy 14.8 16.3 10.1
Esophagectomy 28.2 42.0 48.9
Pancreas Resection 44.6 52 16.6
Gastrectomy 9.8 20.2 106.1
Lung Lobectomy 7.1 14.2 100.0
Other
CABG 41 21.1 -48.5
CEA 26.4 21.4 -18.9
Thyroidectomy 22.4 25.2 12.5
Medium Volume Surgeon Share (%)
1999 2005 % Change
Oncologic
Colectomy 20.2 24.2 19.8
Esophagectomy 15.7 16.3 3.8
Pancreas Resection 15.2 27.2 78.9
Gastrectomy 15.3 18.9 23.5
Lung Lobectomy 15.7 21.6 37.6
Other
CABG 44.6 52.2 17.0
CEA 62.4 69.1 10.7
Thyroidectomy 18.7 29.6 58.3
Low Volume Surgeon Share (%)
1999 2005 % Change
Oncologic
Colectomy 65 59.5 -8.5
Esophagectomy 56.1 41.7 -25.7
Pancreas Resection 40.2 20.8 -48.3
Gastrectomy 74.9 60.9 -18.7
Lung Lobectomy 77.2 64.2 -16.8
Other
CABG 14.4 26.7 85.4
CEA 11.2 9.5 -15.2







The absolute number of high-volume surgeons increased most dramatically for 
pancreas resection (11 in 1999, 23 in 2005), and decreased most dramatically for CABG 
(74 in 1999, 30 in 2005) (Table 8).  The number of medium-volume surgeons almost 
doubled over time for pancreatectomy and thyroidectomy.  
 



































Year 1999 High Volume N 68 4 11 15 5 74 53 24Medium Volume N 191 5 23 48 22 169 608 67
Low Volume N 2592 119 145 641 738 728 910 1509
High Volume N 72 7 23 23 8 30 43 37
Medium Volume N 205 8 40 49 36 153 530 138
Low Volume N 2052 101 79 469 630 776 659 1292
Year 2005
 
Unadjusted Patient Outcomes 
Unadjusted overall mortality rates improved for all procedures except pancreas 
resection between 1999 and 2005.  For this procedure, mortality rates remained similar.  
Endocrine complication rates increased slightly for thyroidectomy from 6.1 to 7.0 
(p<.006) between time periods.  LOS remained relatively stable for all procedures, with 
only slight differences noted for esophagectomy (increase from 15.4 to 16.3 p=NS) and 
gastrectomy, (13.6 to 14.4 p=.043). 
Mortality rates between for high-volume surgeons were lower for all procedures 
compared to their low-volume surgeon counterparts in 1999 (Table 9).  This was 
especially pronounced for colectomy (1.3 vs. 3.5 p<.001), esophagectomy (0 vs. 6.8 
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p=.041), and pancreas resection (2.5 vs. 10.3 p=.016).  Complication rates for 
thyroidectomy were also lower for high-volume surgeons (2.5 vs. 7.1 p<0.001).  These 
differences between high- and low-volume surgeons dissipated over time, however.  For 
example, for colectomy, high-volume surgeons had a 1.3% mortality rate in 1999 and a 
2.3% rate in 2005, whereas low-volume surgeons had a decrease in mortality rate from 
3.5% in 1999 to 2.8% in 2005.  Low-volume surgeons had improved outcomes in 2005 
compared to 1999 for pancreas resection, lung lobectomy, CABG, and CEA.   
LOS was lower for high- compared to low-volume surgeons for all procedures in 
both years.  Medium-volume surgeons had LOS values which were between high- and 
low-volume surgeons for all procedures except gastrectomy (in this procedure, medium-
volume surgeons had the longest LOS in both 1999 and 2005). 
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Table 9: Unadjusted Outcomes According to Surgeon Volume by Year*
Calander Year 1999 2005
Surgeon Volume Cohorts High Med Low p value* High Med Low p value*
Oncologic Procedures
Colectomy
Mortality (%) 1.3 2.6 3.5 0.001 2.3 2.2 2.8 NS
Mean length of stay (d) 8.5 9.4 10.0 0.001 8.1 9.1 9.7 0.001
(95% CI) (8.3-8.7) (9.2-9.6) (9.8-10.1) (7.9-8.4) (8.9-9.3) (9.5-9.9)
Esophagectomy
Mortality (%) 0.0 9.8 6.8 0.041 0.6 6.5 8.8 0.003
Mean length of stay (d) 11.2 14.3 17.4 0.001 12.5 16.1 18.5 0.002
(95% CI) (9.0-13.4) (11.1-17.5) (15.4-19.3) (10.7-14.3) (12.0-20.2) (15.7-21.4)
Pancreas Resection
Mortality (%) 2.5 5.5 10.3 0.016 2.5 5.8 9.0 NS
Mean length of stay (d) 13.3 18.1 20.6 0.001 13.6 14.9 24.1 0.001
(95% CI) (11.9-14.6) (15.6-20.6) (18.1-23.1) (12.2-15.1) (13.0-16.7) (19.8-28.5)
Gastrectomy
Mortality (%) 4.0 8.4 6.6 NS 3.8 5.2 6.8 NS
Mean length of stay (d) 11.4 14.7 14.0 0.043 13.0 16.5 14.8 0.038
(95% CI) (10.0-12.8) (12.9-16.6) (13.2-14.8) (11.4-14.5) (13.8-19.1) (13.8-15.7)
Lung Lobectomy
Mortality (%) 2.5 2.8 3.9 NS 1.4 3.4 3.3 0.017
Mean length of stay (d) 7.1 8.0 9.1 0.001 6.4 8.3 8.9 0.001
(95% CI) (6.5-7.8) (7.7-8.4) (8.9-9.4) (6.0-6.8) (7.8-8.7) (8.7-9.2)
Other Procedures
CABG
Mortality (%) 2.4 2.7 4.1 0.001 2.0 2.2 2.3 NS
Mean length of stay (d) 8.9 8.8 9.7 0.001 9.1 9.2 9.6 0.001
(95% CI) (8.8-9.0) (8.7-8.9) (9.5-9.9) (8.9-9.3) (9.1-9.3) (9.4-9.7)
CEA
Mortality (%) 0.5 0.5 1.0 0.010 0.2 0.4 0.4 NS
Mean length of stay (d) 2.7 3.1 4.5 0.001 2.3 2.7 3.9 0.001
(95% CI) (2.6-2.8) (3.0-3.2) (4.2-4.7) (2.3-2.6) (2.6-2.8) (3.7-4.2)
Thyroidectomy
Endocrine Complications (%) 2.5 6.1 7.1 0.001 4.9 8.9 7.9 0.001
Mean length of stay (d) 1.4 1.8 2.4 0.001 1.3 2.4 2.3 0.001
(95% CI) (1.3-1.5) (1.7-1.9) (2.1-2.7) (1.3-1.4) (2.1-2.6) (2.1-2.4)
NS = not significant; CI indicates confidence interval
* Based on Chi squared analyses for mortality and analysis of variance for LOS; signifiance set at α=0.05  
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Table 10: Adjusted Outcomes for Low Volume Surgeons±
Oncologic Procedures Calander Year 1999 p value* 2005 p value*
Colectomy
In-Hospital Mortality Adjusted OR 2.2 (1.4-3.3) 0.001 1.0 (0.7-1.4) NS
Estimated Increase in Length of Stay (d) 1.1 (0.7-1.4) 0.001 0.8 (0.4-1.1) 0.001
Esophagectomy
In-Hospital Mortality Adjusted OR 10 (-9.0-20.0) NS 3.8 (0.2-60.8) NS
Estimated Increase in Length of Stay (d) 5.0 (1.4-8.5) 0.001 5.3 (0.6-10.0) 0.05
Pancreas Resection
In-Hospital Mortality Adjusted OR 5.8 (1.0-34.8) NS 2.8 (0.8-10.4) NS
Estimated Increase in Length of Stay (d) 7.6 (3.4-11.7) 0.001 9.5 (5.2-13.8) 0.001
Gastrectomy
In-Hospital Mortality Adjusted OR 0.7 (0.2-2.4) NS 0.8 (0.3-2.3) NS
Estimated Increase in Length of Stay (d) 1.6 (-1.0-4.2) NS 0.8 (-1.6-3.1) NS
Lung Lobectomy
In-Hospital Mortality Adjusted OR 1.6 (0.7-3.9) NS 1.5 (0.7-3.3) NS
Estimated Increase in Length of Stay (d) 2.8 (2.0-3.7) 0.001 1.7 (1.0-2.4) 0.001
Other Procedures
CABG
In-Hospital Mortality Adjusted OR 1.5 (1.2-1.8) 0.001 1.1 (0.8-1.5) NS
Estimated Increase in Length of Stay (d) 1.0 (0.7-1.2) 0.001 1.0 (0.6-1.3) 0.001
CEA
In-Hospital Mortality Adjusted OR 1.5 (0.7-2.8) NS 1.7 (0.5-5.7) NS
Estimated Increase in Length of Stay (d) 1.4 (1.2-1.5) 0.001 0.9 (0.7-1.1) 0.001
Thyroidectomy
Endocrine Complications Adjusted OR 1.7 (1.0-2.8) 0.05 1.1 (0.8-1.5) NS
Estimated Increase in Length of Stay (d) 0.8 (0.1-1.5) 0.05 0.3 (0.1-0.6) 0.05
±reference is high volume surgeon cohort : adjustments made for patient and provider characteristics
OR = Odds Ratio (95% CI)
*signifiance set at α=0.05  
 
Adjusted Patient Outcomes 
Low-volume surgeons had statistically similar mortality rates compared to high-
volume surgeons for esophagectomy, gastrectomy, lung-lobectomy, and pancreatectomy 
after adjustment for patient and provider characteristics in 1999, and all procedures by 
2005 (Table 10).  For thyroidectomy, endocrine complication rates were higher for high- 
compared to low-volume surgeons in 1999, but statistically similar by 2005.   
Low-volume surgeons had a significantly longer inpatient LOS compared to high-
volume surgeons for all procedures even after adjustment in both years except 
gastrectomy in 1999.  These differences attenuated slightly over time for colectomy, 




























This is the first study to our knowledge to demonstrate changes in surgeon 
volume referral patterns over time for procedures shown in the literature to have a strong 
surgeon volume-outcome association.  For most procedures, the percentage of patients 
seeking care from a high-volume surgeon increased significantly between 1999 and 2005.  
For CEA and CABG, there was a decrease in high-volume surgeon share over time.  This 
is likely related to the 27% decline in overall procedure volume for CABG and 16% 
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decrease for CEA, suggesting the potential need to lower what defines a high-volume 
surgeon for these procedures (Table 5).   
The increased share of patients seeking care from a high-volume surgeon may 
reflect an increased public awareness of potential benefits. [5] Physicians may also be 
sending more patients to high-volume surgeons because of mounting evidence in the 
scholarly literature supporting this practice throughout the last decade.[5] 
Referral patterns to high-volume surgeons are not likely related to Leapfrog 
hospital referral policies.  Of the eight procedures analyzed in this study, only three have 
Leapfrog hospital volume standards.  These include esophagectomy, CABG, and CEA. 
While high-volume surgeons predominately practice at high-volume hospitals (Table 4), 
this association decreased for most procedures over time.  This suggests other factors 
may be influencing the increasing number of patients seeking care from a high-volume 
surgeon.   
Increasingly, general surgeons are narrowing their focus of practice.[11]  This is 
reflected by the existence of a spectrum of new fellowships that are self-designated, or 
society sponsored which do not lead to American Board of Medical Specialist 
certification.  This study shows that there has been an increase in the absolute number of 
high-volume surgeons for all procedures.  This phenomenon may be related to increasing 
demands of patients seeking care from high volume surgeons.[27] Thus, there are likely 
multiple forces contributing to the increased share of patients seeking care from high-






This study shows that low-volume surgeons have higher unadjusted mortality 
rates than high-volume surgeons for colectomy, esophagectomy, and pancreatectomy in 
1999, and esophagectomy and lobectomy in 2005.  After adjustment for patient and 
provider characteristics, low-volume surgeons have a higher mortality rate for colectomy 
in 1999.  By 2005, there were no differences in mortality rates (or complication rates for 
thyroidectomy) between high- and low-volume surgeons for any procedure.  Low-volume 
surgeons appear to have improved clinical outcomes (mortality, or endocrine 
complications for thyroidectomy) over time, matching the high-volume surgeon group by 
2005. 
Significant differences in LOS persisted after adjustment over time for all 
procedures except gastrectomy in 2005.  This has important implications.  Low-volume 
surgeons may have higher post-operative complication rates, necessitating a longer 
hospital stay by their patients.  While cost was not directly evaluated in this study, longer 
LOS may be related to cost [15].  Thus, high-volume surgeons may be more cost-
efficient, although this would need to be validated another study.  
It is unknown whether high-volume surgeons have shorter LOS because of 
inherent differences in surgical skill or because of superior pre- and/or post-operative 
surgical pathways.  As Donabedian described, the factors which influence surgical 
outcomes can be divided theoretically into structural or process measures.[26, 27]  An 
example of a structural measure is a high-volume surgeon’s superior intra-operative skill.  
Process measures include the appropriate use of pre-operative prophylactic antibiotics or 
peri-operative beta blockade.  
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For the procedures in this study, there may be components of both structure and 
process factors related to the increased LOS by low- compared to high-volume surgeons.  
High-volume surgeons may be better equipped to recognize and deal with post-operative 
complications.  Alternatively, they may be using superior judgment when determining 
which patients will benefit from a given operation.  For example, in pancreas resection 
for cancer, Maa et al. has shown that high-volume surgeons perform more cost-effective 
diagnostic tests than low-volume surgeons.  They readily use preoperative thin cut 
pancreas protocol CT scans, and avoid unnecessary tests like percutaneous pancreatic 
biopsies.[28]  The same is true for less risky procedures.  While no data exist for 
thyroidectomy, for parathyroidectomy it has been well established that formal guidelines 
established by the National Institutes of Health are adhered to less often by low- 
compared to high-volume surgeons.[29]   
Despite differences in patient demographics by surgeon volume group, patients 
had remarkably similar comorbidities for most procedures.  This finding lends support to 
the notion that high-volume surgeons have patients with a shorter LOS independent of 
patient comorbidity, since they are not operating on a healthier group.   
High-volume surgeons see patients who are disproportionately younger, 
wealthier, have private insurance, or are white. (Table 6)  Given that few high-volume 
surgeons exist in the U.S., these patients may have better means of accessing these 
surgeons (Table 8).  For thyroidectomy, there are data showing that increased age and 
race are independently associated with increased complication rates, costs, and LOS, 
especially when the procedure is performed by a low-volume surgeon.[21]   This study 
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shows that patients most likely to benefit from a shorter LOS are the same patients who 
are least likely to have their operations performed by a high-volume surgeon. 
One goal of this study is to inform policy makers.  One interpretation of our 
results may be the idea that surgeon-volume standards should be incorporated into policy 
just has been done for hospital volume.  We believe it is dangerous to set policy without 
further studies because of concern for under-adjustment of confounders unique to 
individual surgeons and procedures.  One concern is that there are too many patients to be 
cared for by the limited number high-volume surgeons in the US.  Thus, surgeon-volume 
standards may conceivably make patient access difficult.  Policies should only be 
established after careful analysis of their implications. 
Study Limitations 
The limitations to our study include those inherent in any administrative 
databases.  This study is inherently retrospective with all the limitations known to such a 
study.  Since we relied upon ICD-9 procedure and diagnosis codes to extract patient 
cases, there is a potential for coding error.  We did our best to identify errors and make 
corrections when necessary; however, this was rare and has not been shown to be 
pervasive in HCUP-NIS.   
Though the aim of this study was to identify referral patterns nationally, HCUP-
NIS only captures a 20% sample of all US hospitals and does not include federal 
hospitals such as Veterans Affairs hospitals.   
Another limitation inherent to HCUP-NIS is that it lacks important patient 
information, such as social gradients (e.g. patient education level or occupation), which 
conceivably could influence patients’ access to high-volume surgeons or their 
 35
outcomes.[30]  In addition, HCUP-NIS does not contain stage of disease information, and 
therefore there may be some error related to adjustment for severity of illness.   
Since the HCUP-NIS data in this study were a cross-sectional sample of patients 
in 1999 and 2005, longitudinal data were not available.  Thus, distinguishing between 
complications and comorbidities is difficult.  Our method has been validated for 
administrative databases, however, and has been used by others in related administrative 
database studies.  Further, our comorbidity measurements are consistent with those in the 
literature.[22-25]  Given that HCUP-NIS is a national sample without patient identifying 
information, checking the accuracy of reporting via chart review for complications and 
comorbidities is not possible.   
Technological advances for surgical procedures may play a role in outcome 
differences between surgeon volume groups and are difficult to capture in HCUP-NIS.  
We did control for laparoscopy rates for colectomy and thoracoscopy for lung-lobectomy 
in our adjusted mortality and LOS outcomes.  The number of surgeons who used this 
technology did change over time; however, its use did not affect our results.(Table 11) 
Table 11: Laparosopic / Thoracoscopic Usage Rates
1999 2005
High Med Low High Med Low
p value p value
Colectomy (%) 2.5 0.8 1.1 0.001 6.8 3.6 3.1 0.001
Lung Lobectomy (%) 1.9 6.1 4.3 0.009 5.4 6.4 6.1 NS  
Lastly, we identified surgeons using unique surgeon identifiers, however, 
individual surgeons may have multiple identifiers if s/he practices in multiple hospitals.  
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'4571 ' '78 ' MULT SEG LG BOWEL EXCIS
'4572 ' '78 ' CECECTOMY
'4573 ' '78 ' RIGHT HEMICOLECTOMY
'4574 ' '78 ' TRANSVERSE COLON RESECT
'4575 ' '78 ' LEFT HEMICOLECTOMY (Begin 1988)
'4576 ' '78 ' SIGMOIDECTOMY
'4579 ' '78 ' PART LG BOWEL EXCIS NEC
'458  ' '78 ' TOT INTRA-ABD COLECTOMY
'4849 ' '78 ' PULL-THRU RECT RESEC NEC
'485  ' '78 ' ABD-PERINEAL RECT RESECT
'4861 ' '78 ' TRANSSAC RECTOSIGMOIDECT
'4862 ' '78 ' ANT RECT RESECT W COLOST
'4863 ' '78 ' ANTERIOR RECT RESECT NEC
'4864 ' '78 ' POSTERIOR RECT RESECTION
'4866 ' '78 ' HARTMANN RESECTION RECTUM (Begin 1980, End 1988)
'4869 ' '78 ' RECTAL RESECTION NEC
Primary Diagnosis
ICD9 CCS
'1530 ' '14   ' MAL NEO HEPATIC FLEXURE
'1531 ' '14   ' MAL NEO TRANSVERSE COLON
'1532 ' '14   ' MAL NEO DESCEND COLON
'1533 ' '14   ' MAL NEO SIGMOID COLON
'1534 ' '14   ' MALIGNANT NEOPLASM CECUM
'1535 ' '14   ' MALIGNANT NEO APPENDIX
'1536 ' '14   ' MALIG NEO ASCEND COLON
'1537 ' '14   ' MAL NEO SPLENIC FLEXURE
'1538 ' '14   ' MALIGNANT NEO COLON NEC
'1539 ' '14   ' MALIGNANT NEO COLON NOS
'1540 ' MAL NEO RECTOSIGMOID JCT




'4240 ' ESOPHAGECTOMY NOS
'4241 ' PARTIAL ESOPHAGECTOMY
'4242 ' TOTAL ESOPHAGECTOMY
Primary Diagnosis
ICD9 CCS
'1500 ' '12   ' MAL NEO CERVICAL ESOPHAG
'1501 ' '12   ' MAL NEO THORACIC ESOPHAG
'1502 ' '12   ' MAL NEO ABDOMIN ESOPHAG
'1503 ' '12   ' MAL NEO UPPER 3RD ESOPH
'1504 ' '12   ' MAL NEO MIDDLE 3RD ESOPH
'1505 ' '12   ' MAL NEO LOWER 3RD ESOPH
'1508 ' '12   ' MAL NEO ESOPHAGUS NEC
'1509 ' '12   ' MAL NEO ESOPHAGUS NOS
'1510 ' MAL NEO STOMACH CARDIA




'062  ' UNILAT THYROID LOBECTOMY
'0631 ' EXCISION THYROID LESION
'0639 ' PART THYROIDECTOMY NEC
'064  ' COMPLETE THYROIDECTOMY
'0650 ' SUBSTERN THYROIDECT NOS
'0651 ' PART SUBSTERN THYROIDECT




'3812 ' HEAD & NECK ENDARTER NEC
Secondary Procedure Exclusions
ICD9 CCS
'3500 ' '43 ' CLOSED VALVOTOMY NOS
'3501 ' '43 ' CLOSED AORTIC VALVOTOMY
'3502 ' '43 ' CLOSED MITRAL VALVOTOMY
'3503 ' '43 ' CLOSED PULMON VALVOTOMY
'3504 ' '43 ' CLOSED TRICUSP VALVOTOMY
'3510 ' '43 ' OPEN VALVULOPLASTY NOS
'3511 ' '43 ' OPN AORTIC VALVULOPLASTY
'3512 ' '43 ' OPN MITRAL VALVULOPLASTY
'3513 ' '43 ' OPN PULMON VALVULOPLASTY
'3514 ' '43 ' OPN TRICUS VALVULOPLASTY
'3520 ' '43 ' REPLACE HEART VALVE NOS
'3521 ' '43 ' REPLACE AORT VALV-TISSUE
'3522 ' '43 ' REPLACE AORTIC VALVE NEC
'3523 ' '43 ' REPLACE MITR VALV-TISSUE
'3524 ' '43 ' REPLACE MITRAL VALVE NEC
'3525 ' '43 ' REPLACE PULM VALV-TISSUE
'3526 ' '43 ' REPLACE PULMON VALVE NEC
'3527 ' '43 ' REPLACE TRIC VALV-TISSUE
'3528 ' '43 ' REPLACE TRICUSP VALV NEC
'3596 ' '43 ' PERC HEART VALVULOPLASTY (Begin 1986)
'3599 ' '43 ' OTHER HEART VALVE OPS
'3610 ' '44 ' AORTOCORONARY BYPASS NOS
'3611 ' '44 ' AORTOCOR BYPAS-1 COR ART
'3612 ' '44 ' AORTOCOR BYPAS-2 COR ART
'3613 ' '44 ' AORTOCOR BYPAS-3 COR ART
'3614 ' '44 ' AORTCOR BYPAS-4+ COR ART
'3615 ' '44 ' 1 INT MAM-COR ART BYPASS
'3616 ' '44 ' 2 INT MAM-COR ART BYPASS
'3617 ' '44 ' ABD-CORON ART BYPASS (Begin 1996)
'3619 ' '44 ' HRT REVAS BYPS ANAS NEC
'362  ' '44 ' ARTERIAL IMPLANT REVASC
'363  ' '44 ' HEART REVASCULARIZAT NEC (End 1998)
'3631 ' '44 ' OPEN CHEST TRANSMYO REVASC (Begin 1998)
'3632 ' '44 ' OTH TRANSMYO REVASC (Begin 1998)
'3633 ' '44 ' ENDO TRANSMYO REVASCULAR (Begin 2006)
'3634 ' '44 ' PERC TRANSMYO REVASCULAR (Begin 2006)
'3639 ' '44 ' OTHER HEART REVASC (Begin 1998)
'0066 ' '45 ' PTCA OR CORONARY ATHER (Begin 2005)
'3601 ' '45 ' PTCA-1 VESSEL W/O AGENT (Begin 1986, End 2005)
'3602 ' '45 ' PTCA-1 VESSEL WITH AGNT (Begin 1986, End 2005)
'3605 ' '45 ' PTCA-MULTIPLE VESSEL (Begin 1986, End 2005)
'3604 ' '46 ' INTRCORONRY THROMB INFUS (Begin 1986)
'3721 ' '47 ' RT HEART CARDIAC CATH
'3722 ' '47 ' LEFT HEART CARDIAC CATH
'3723 ' '47 ' RT/LEFT HEART CARD CATH
'8852 ' '47 ' RT HEART ANGIOCARDIOGRAM
'8853 ' '47 ' LT HEART ANGIOCARDIOGRAM
'8854 ' '47 ' RT & LT HEART ANGIOCARD
'8855 ' '47 ' CORONAR ARTERIOGR-1 CATH
'8856 ' '47 ' CORONAR ARTERIOGR-2 CATH
'8857 ' '47 ' CORONARY ARTERIOGRAM NEC
'49 ' 'Ot OR heart '
'3808 ' EMBOLECTOMY LEG VESSEL
'3804 ' INCISION OF AORTA
'3814 ' ENDARTERECTOMY OF AORTA
'3815 ' THORACIC ENDARTERECTOMY
'3816 ' ABDOMINAL ENDARTERECTOMY
'3818 ' ENDARTERECTOMY LEG VESL
'3835 ' THOR VESSEL RESECT/ANAST
'3836 ' ABD VESSEL RESECT/ANAST
'3837 ' ABD VEIN RESECT & ANAST
'3838 ' LEG ARTERY RESECT/ANAST
'52 ' AORTA RESECTION & ANAST
'52 ' RESECT ABDM AORTA W REPL (Begin 1986)
'52 ' EXCISION OF AORTA
'52 ' ENDOVASCULAR IMPLANT IN ABDM AORTA (Begin 2000)
'52 ' ENDO IMP GRFT THOR AORTA (Begin 2005)
'52 ' OTHER ENDOVASCULAR REPAIR OF ANEURYSM (Begin 2000)
'50 ' EXTRACORPOREAL CIRCULAT
'50 ' HYPOTHERMIA W OPEN HEART
'50 ' CARDIOPLEGIA
'50 ' INTRAOP CARDIAC PACEMAK
'50 ' EXTRACORPOREAL MEMB OXY (Begin 1988)
'50 ' PER CARDIOPULMON BYPASS (Begin 1990)
Coronary Artery Bypass Graft Surgery 38
Primary Procedure
ICD9
'3610 ' AORTOCORONARY BYPASS NOS
'3611 ' AORTOCOR BYPAS-1 COR ART
'3612 ' AORTOCOR BYPAS-2 COR ART
'3613 ' AORTOCOR BYPAS-3 COR ART
'3614 ' AORTCOR BYPAS-4+ COR ART
'3615 ' 1 INT MAM-COR ART BYPASS
'3616 ' 2 INT MAM-COR ART BYPASS
'3617 ' ABD-CORON ART BYPASS (Begin 1996)
'3619 ' HRT REVAS BYPS ANAS NEC
'362  ' ARTERIAL IMPLANT REVASC
Secondary Procedure Exclusions
CCS
'43 ' CLOSED VALVOTOMY NOS
'43 ' CLOSED AORTIC VALVOTOMY
'43 ' CLOSED MITRAL VALVOTOMY
'43 ' CLOSED PULMON VALVOTOMY
'43 ' CLOSED TRICUSP VALVOTOMY
'43 ' OPEN VALVULOPLASTY NOS
'43 ' OPN AORTIC VALVULOPLASTY
'43 ' OPN MITRAL VALVULOPLASTY
'43 ' OPN PULMON VALVULOPLASTY
'43 ' OPN TRICUS VALVULOPLASTY
'43 ' REPLACE HEART VALVE NOS
'43 ' REPLACE AORT VALV-TISSUE
'43 ' REPLACE AORTIC VALVE NEC
'43 ' REPLACE MITR VALV-TISSUE
'43 ' REPLACE MITRAL VALVE NEC
'43 ' REPLACE PULM VALV-TISSUE
'43 ' REPLACE PULMON VALVE NEC
'43 ' REPLACE TRIC VALV-TISSUE
'43 ' REPLACE TRICUSP VALV NEC
'43 ' PERC HEART VALVULOPLASTY (Begin 1986)
'43 ' OTHER HEART VALVE OPS
'49 ' PAPILLARY MUSCLE OPS
'49 ' CHORDAE TENDINEAE OPS
'49 ' ANNULOPLASTY
'49 ' INFUNDIBULECTOMY
'49 ' TRABECUL CARNEAE CORD OP
'49 ' TISS ADJ TO VALV OPS NEC
'49 ' ENLARGE EXISTING SEP DEF
'49 ' CREATE SEPTAL DEFECT
'49 ' PROSTH REP HRT SEPTA NOS
'49 ' PROS REP ATRIAL DEF-OPN
'49 ' PROS REPAIR ATRIA DEF-CL
'49 ' PROST REPAIR VENTRIC DEF
'49 ' PROS REP ENDOCAR CUSHION
'49 ' PROS REP VENTRC DEF-CLOS (Begin 2006)
'49 ' GRFT REPAIR HRT SEPT NOS
'49 ' GRAFT REPAIR ATRIAL DEF
'49 ' GRAFT REPAIR VENTRIC DEF
'49 ' GRFT REP ENDOCAR CUSHION
'49 ' HEART SEPTA REPAIR NOS
'49 ' ATRIA SEPTA DEF REP NEC
'49 ' VENTR SEPTA DEF REP NEC
'49 ' ENDOCAR CUSHION REP NEC
'49 ' TOT REPAIR TETRAL FALLOT
'49 ' TOTAL REPAIR OF TAPVC
'49 ' TOT REP TRUNCUS ARTERIOS
'49 ' TOT COR TRANSPOS GRT VES (Begin 1988)
'49 ' INTERAT VEN RETRN TRANSP
'49 ' CONDUIT RT VENT-PUL ART
'49 ' CONDUIT LEFT VENTR-AORTA
'49 ' CONDUIT ARTIUM-PULM ART
'49 ' HEART REPAIR REVISION
'49 ' OTHER HEART SEPTA OPS
'49 ' REM OBSTR NOS (Begin 1986, End 1991)
'49 ' OPEN CORONRY ANGIOPLASTY (Begin 1986)
'49 ' (OTH)REM COR ART OBST(NEC) (Begin 1986)
'49 ' HEART ANEURYSM EXCISION
'49 ' EXC(/DEST) OTH HRT LESION (Begin 1988)
'49 ' CATH ABLATION LES HEART (Begin 1988)
'49 ' PARTIAL VENTRICULECTOMY (Begin 1997)
'49 ' HEART & PERICARD REPAIR
'49 ' IMPL CARDIAC SUPPORT DEV (Begin 2005)
'49 ' HEART/PERICARD REPR NEC (Begin 2005)
'49 ' IMPLANTATION OF TOTAL REPLACEMENT HEART SYST (Begin 200
'49 ' REPLACEMENT OR REPAIR OF THORACIC UNIT OF TO (Begin 200
'49 ' REPLACEMENT OR REPAIR OF OTHER IMPLANTABLE C (Begin 200
'49 ' IMPLANT HRT ASST SYS NEC
'49 ' REPLACE HRT ASSIST SYST
'49 ' REMOVE HEART ASSIST SYS
'49 ' IMPL EXTERN HEART ASSIST (Begin 1995)
'49 ' IMPL INTERN HEART ASSIST (Begin 1995)
'49 ' IMPLANT CARDIOMYOSTIM SYS (Begin 1998)
'49 ' PERCUTAN HRT ASSIST SYST (Begin 2004)
'49 ' INS LEFT ATR APPEND DEV (Begin 2004)
'49 ' OTHER HEART/PERICARD OPS
'52 ' AORTA RESECTION & ANAST
'52 ' RESECT ABDM AORTA W REPL (Begin 1986)
'52 ' EXCISION OF AORTA
'52 ' ENDOVASCULAR IMPLANT IN ABDM AORTA (Begin 2000)
'52 ' ENDO IMP GRFT THOR AORTA (Begin 2005)




'526  ' TOTAL PANCREATECTOMY
'527  ' RAD PANCREATICODUODENECT
Primary Diagnosis
ICD9 CCS
'1570 ' '17   ' MAL NEO PANCREAS HEAD
'1571 ' '17   ' MAL NEO PANCREAS BODY
'1572 ' '17   ' MAL NEO PANCREAS TAIL
'1573 ' '17   ' MAL NEO PANCREATIC DUCT
'1574 ' '17   ' MAL NEO ISLET LANGERHANS
'1578 ' '17   ' MALIG NEO PANCREAS NEC




'435  ' '74 ' PROXIMAL GASTRECTOMY
'436  ' '74 ' DISTAL GASTRECTOMY
'437  ' '74 ' PART GASTREC W JEJ ANAST
'4381 ' '74 ' PART GAST W JEJ TRANSPOS
'4389 ' '74 ' PARTIAL GASTRECTOMY NEC
'4391 ' '74 ' TOT GAST W INTES INTERPO
'4399 ' '74 ' TOTAL GASTRECTOMY NEC
Primary Diagnosis
ICD9 CCS
'1510 ' '13   ' MAL NEO STOMACH CARDIA
'1511 ' '13   ' MALIGNANT NEO PYLORUS
'1512 ' '13   ' MAL NEO PYLORIC ANTRUM
'1513 ' '13   ' MAL NEO STOMACH FUNDUS
'1514 ' '13   ' MAL NEO STOMACH BODY
'1515 ' '13   ' MAL NEO STOM LESSER CURV
'1516 ' '13   ' MAL NEO STOM GREAT CURV
'1518 ' '13   ' MALIG NEOPL STOMACH NEC




'3221 ' '36 ' EMPHYSEMA BLEB PLICATION
'3222 ' '36 ' LUNG VOL REDUCT SURG (Begin 1995)
'3223 ' '36 ' OPEN ABLTN LUNG LES/TISS (Begin 2006)
'3224 ' '36 ' PERC ABLTN LUNG LES/TISS (Begin 2006)
'3225 ' '36 ' THOR ABLTN LUNG LES/TISS (Begin 2006)
'3226 ' '36 ' ABLTN LUNG TISS NEC/NOS (Begin 2006)
'3229 ' '36 ' DESTROY LOC LUNG LES NEC
'323  ' '36 ' SEGMENTAL LUNG RESECTION
'324  ' '36 ' LOBECTOMY OF LUNG
'325  ' '36 ' COMPLETE PNEUMONECTOMY
Primary Diagnosis
ICD9 CCS
'1622 ' '19   ' MALIG NEO MAIN BRONCHUS
'1623 ' '19   ' MAL NEO UPPER LOBE LUNG
'1624 ' '19   ' MAL NEO MIDDLE LOBE LUNG
'1625 ' '19   ' MAL NEO LOWER LOBE LUNG
'1628 ' '19   ' MAL NEO BRONCH/LUNG NEC
'1629 ' '19   ' MAL NEO BRONCH/LUNG NOS
'2312 ' '19   ' CA IN SITU BRONCHUS/LUNG
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